Panic disorder: strategies for long-term treatment. 1991

G L Klerman
Department of Psychiatry, Cornell University Medical College, New York, N.Y.

Issues in the treatment of panic disorder now focus on long-term maintenance treatment with medication. The author sets the stage for our current understanding of panic disorder by describing the historical development of our knowledge of this disorder, past and current psychiatric diagnostic systems, and the symptoms of panic disorder. He states that this supplement reviews much of the great amount of research done on panic disorder in the 1980s and concludes with descriptions of each of the papers in this supplement.

UI MeSH Term Description Entries
D010200 Panic A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function. Panics
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000525 Alprazolam A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) Alprazolan,Alprox,Apo-Alpraz,Cassadan,D-65MT,Esparon,Kalma,Novo-Alprazol,Nu-Alpraz,Ralozam,Tafil,Trankimazin,U-31,889,Xanax,Apo Alpraz,D65MT,Novo Alprazol,Nu Alpraz,U31,889
D001008 Anxiety Disorders Persistent and disabling ANXIETY. Anxiety Neuroses,Anxiety States, Neurotic,Neuroses, Anxiety,Anxiety Disorder,Anxiety State, Neurotic,Disorder, Anxiety,Disorders, Anxiety,Neurotic Anxiety State,Neurotic Anxiety States,State, Neurotic Anxiety,States, Neurotic Anxiety

Related Publications

G L Klerman
February 1991, The Journal of clinical psychiatry,
G L Klerman
January 1993, Journal of psychiatric research,
G L Klerman
January 1998, The Journal of clinical psychiatry,
G L Klerman
November 1990, The Journal of clinical psychiatry,
G L Klerman
January 1994, Harvard review of psychiatry,
G L Klerman
January 1995, The British journal of psychiatry : the journal of mental science,
G L Klerman
December 1998, Journal of clinical psychopharmacology,
Copied contents to your clipboard!